Patents by Inventor Christopher Robert Lashinski

Christopher Robert Lashinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Deployment restraint and delivery system for implantable cardiac device
    Patent number: 11523905
    Abstract: Features for a restraint, such as a cap, are described. The restraint secures a cardiac device in a collapsed, delivery configuration for transcatheter delivery to a heart. The restraint may have a tubular sidewall extending from a proximal end to a distal end, a proximal opening defined by the sidewall at the proximal end and a channel defined by the sidewall and extending distally from the proximal opening. The restraint is configured to receive the implant in the collapsed configuration through the proximal opening to radially restrain the implant within the channel. The restraint eliminates the need for a surrounding sheath, reducing the delivery profile and size of the overall delivery system, among other advantages. The restraint may have an atraumatic leading edge to reduce the risk of injury to the patient.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: December 13, 2022
    Assignee: Boston Scientific Scimed, Inc.
    Inventors: Erik Christopher Griswold, Christopher Robert Lashinski, Randall Lashinski, Michael J. Lee, Nathan D. Brown
  • DEPLOYMENT RESTRAINT AND DELIVERY SYSTEM FOR IMPLANTABLE CARDIAC DEVICE
    Publication number: 20200022811
    Abstract: Features for a restraint, such as a cap, are described. The restraint secures a cardiac device in a collapsed, delivery configuration for transcatheter delivery to a heart. The restraint may have a tubular sidewall extending from a proximal end to a distal end, a proximal opening defined by the sidewall at the proximal end and a channel defined by the sidewall and extending distally from the proximal opening. The restraint is configured to receive the implant in the collapsed configuration through the proximal opening to radially restrain the implant within the channel. The restraint eliminates the need for a surrounding sheath, reducing the delivery profile and size of the overall delivery system, among other advantages. The restraint may have an atraumatic leading edge to reduce the risk of injury to the patient.
    Type: Application
    Filed: July 17, 2019
    Publication date: January 23, 2020
    Inventors: Erik Christopher Griswold, Christopher Robert Lashinski, Randall Lashinski, Michael J. Lee